|
|
|
 INTERMACS is a national registry for patients who are receiving mechanical circulatory support device therapy to treat advanced heart failure. This registry was established as a joint effort of the National Heart, Lung and Blood Institute (NHLBI), the Centers for Medicare and Medicaid Services (CMS), the Food and Drug Administration (FDA), clinicians, scientists and industry representatives in conjunction with the University of Alabama at Birmingham (UAB) and United Network for Organ Sharing (UNOS). Current INTERMACS Registry TotalsINTERMACS Sites Total Sites Currently Activated: 81 Number of patients entered: 408 INTERMACS completed its first contract period and has been renewed by the National Heart, Lung and Blood Institute (NHLBI). Please go to All Things INTERMACS for additional details regarding the INTERMACS evolution.  |